Free Trial
OTCMKTS:SGBI

Sangui Biotech International (SGBI) Stock Price, News & Analysis

$0.0002 0.00 (0.00%)
As of 05/5/2025

About Sangui Biotech International Stock (OTCMKTS:SGBI)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0002
$0.0002
Volume
N/A
Average Volume
62,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

Receive SGBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sangui Biotech International and its competitors with MarketBeat's FREE daily newsletter.

SGBI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

SGBI Stock Analysis - Frequently Asked Questions

Sangui Biotech International's stock was trading at $0.0002 at the beginning of 2025. Since then, SGBI stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

Shares of SGBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sangui Biotech International investors own include Gray Television (GTN), Gentex (GNTX), Energy Transfer (ET), Old Republic International (ORI), Orchid Island Capital (ORC), Realty Income (O) and Marten Transport (MRTN).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:SGBI
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:SGBI) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners